HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape.

Abstract
Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are also involved in immunomodulation, which might influence the outcome of bacterial infection. Hence, a possible effect of statin treatment on Listeriosis was explored in mice. Statin treatment prior to subsequent L. monocytogenes infection strikingly reduced bacterial burden in liver and spleen (up to 100-fold) and reduced histopathological lesions. Statin-treatment in infected macrophages resulted in increased IL-12p40 and TNF-α and up to 4-fold reduced bacterial burden within 6 hours post infection, demonstrating a direct effect of statins on limiting bacterial growth in macrophages. Bacterial uptake was normal investigated in microbeads and GFP-expressing Listeria experiments by confocal microscopy. However, intracellular membrane-bound cholesterol level was decreased, as analyzed by cholesterol-dependent filipin staining and cellular lipid extraction. Mevalonate supplementation restored statin-inhibited cholesterol biosynthesis and reverted bacterial growth in Listeria monocytogenes but not in listeriolysin O (LLO)-deficient Listeria. Together, these results suggest that statin pretreatment increases protection against L. monocytogenes infection by reducing membrane cholesterol in macrophages and thereby preventing effectivity of the cholesterol-dependent LLO-mediated phagosomal escape of bacteria.
AuthorsSuraj P Parihar, Reto Guler, Dirk M Lang, Harukazu Suzuki, A David Marais, Frank Brombacher
JournalPloS one (PLoS One) Vol. 8 Issue 9 Pg. e75490 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24086542 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Toxins
  • Heat-Shock Proteins
  • Hemolysin Proteins
  • Interleukin-12 Subunit p40
  • Tumor Necrosis Factor-alpha
  • Cholesterol
  • Simvastatin
  • hlyA protein, Listeria monocytogenes
Topics
  • Animals
  • Bacterial Toxins (metabolism)
  • Cell Line
  • Cholesterol (metabolism)
  • Heat-Shock Proteins (metabolism)
  • Hemolysin Proteins (metabolism)
  • Interleukin-12 Subunit p40 (metabolism)
  • Listeria monocytogenes (drug effects, metabolism)
  • Listeriosis (drug therapy, metabolism)
  • Liver (drug effects, metabolism, microbiology)
  • Macrophages (metabolism, microbiology)
  • Mice
  • Mice, Inbred C57BL
  • Phagocytosis (drug effects)
  • Phagosomes (drug effects, metabolism)
  • Simvastatin (pharmacology)
  • Spleen (drug effects, metabolism, microbiology)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: